← Back to Search

Procedure

Cryobiopsy for Gastrointestinal Disorders

N/A
Waitlist Available
Led By Guillermo Tearney, M.D PhD.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial is testing whether a cryobiopsy probe can be used to obtain biopsies from adults in a way that is minimally invasive and can be done in low- and middle-income countries.

Who is the study for?
This trial is for adults scheduled for an elective esophagogastroduodenoscopy with biopsy, who can give informed consent. It's not suitable for anyone where standard care would advise against it.Check my eligibility
What is being tested?
The study tests a cryobiopsy probe as a less invasive way to obtain intestinal tissue samples in adults, which could help diagnose and treat environmental enteric dysfunction (EED) in resource-limited settings.See study design
What are the potential side effects?
Potential side effects of the cryobiopsy procedure may include discomfort at the biopsy site, bleeding, or infection; however, specific risks will be detailed by the research team.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of Cryobiopsy probe

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cryobiopsy probe as a tool for biopsyExperimental Treatment1 Intervention
Cryobiopsy probe, administered to study participants.Testing the efficacy of a novel cryobiopsy probe in acquiring tissue samples.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,946 Previous Clinical Trials
13,204,594 Total Patients Enrolled
Bill and Melinda Gates FoundationOTHER
407 Previous Clinical Trials
22,925,512 Total Patients Enrolled
Guillermo Tearney, M.D PhD.Principal InvestigatorMassachusetts General Hospital

Media Library

Cryobiopsy Probe (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03566160 — N/A
Gastrointestinal Disease Research Study Groups: Cryobiopsy probe as a tool for biopsy
Gastrointestinal Disease Clinical Trial 2023: Cryobiopsy Probe Highlights & Side Effects. Trial Name: NCT03566160 — N/A
Cryobiopsy Probe (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03566160 — N/A
~6 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top